Global Olanzapine Market Size study & Forecast, by Application, by Route of Administration, by Distribution Channel and Regional Analysis, 2023-2030

Description

List of Tables

Global Olanzapine Market is valued at approximately USD 1.84 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 2.3% during the forecast period 2023-2030. Olanzapine is a medication used to treat certain mental health conditions, primarily schizophrenia and bipolar disorder. It belongs to a class of drugs called atypical antipsychotics. Olanzapine works by affecting the levels of certain neurotransmitters in the brain, such as dopamine and serotonin. These chemicals play a role in regulating mood, thoughts, and behavior. The Olanzapine Market is expanding because of factors such as the rising prevalence of schizophrenia in various regions, the surge in government initiatives to provide facilities for mental disorders and increasing consumer awareness regarding various mental disorders.

The Olanzapine Market is growing due to an increase in the frequency of neurological illnesses and a greater demand for the treatment of acute mania in bipolar disorders. Diseases such as schizophrenia are on the rise as the world's population grows at a pace of more than 1% per year, and people aren't receiving enough neutrinos. The prevalence of emotional and mental illnesses is rising as a result of changing lifestyles and increased job and life stress, which is expected to drive lucrative growth in the Olanzapine Market. According to the National Institute of Mental Health (NIH), 52.9 million adults in the United States experienced mental illness in 2020. As a result, an increase in the number of people suffering from mental illnesses that necessitate the use of olanzapine medicine to treat the condition drives market growth. Furthermore, according to World Health Organization (WHO) data in 2022, 1 out of every 8 individuals worldwide suffers from a mental condition. Additionally, in several regions, initiatives to expand investment in new Olanzapine medications are intensifying. This initiative tends to open up new development opportunities for the Olanzapine Market. However, the high cost of olanzapine and its adverse effects hampers the expansion of the Olanzapine Market throughout the forecast period of 2023-2030.

The key regions considered for the Global Olanzapine Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the factors such as the rising prevalence of mental diseases such as schizophrenia in the region, high insurance penetration and medical facilities, geographical expansion of key players in the region and favorable regulatory requirements. Asia Pacific is expected to grow significantly over the forecast period. This is attributed to increased government efforts to encourage a healthy lifestyle. Furthermore, the increasing number of medication stores and retail pharmacies selling olanzapine pharmaceuticals in the region contributes to market growth.

Major market player included in this report are:

Bristol-Myers Squibb Company
Dr. Reddy's Laboratories Ltd
Endo International plc
Teva Pharmaceutical Industries Ltd
Sun Pharmaceutical Industries Ltd
Mylan N.V.
Novartis AG
Lupin Ltd.
Cipla Inc
Eli Lily and Company

Recent Developments in the Market:

In November 2023, Royalty Pharma plc and Teva Pharmaceuticals International GmbH, a subsidiary of Teva Pharmaceutical Industries Ltd., have revealed a collaboration aimed at expediting the clinical research program for Teva's olanzapine LAI (TEV-'749). This collaboration involves a funding agreement valued at USD 125 million to cover program costs. This funding arrangement allowed company to continue to advance the development of olanzapine LAI (TEV-'749), a vital initiative for Teva Pharmaceuticals, while preserving the company's resources for more advanced and futuristic formulations.
In October 2023, Coya Therapeutics, Inc., and Dr. Reddy's Laboratories formed an exclusive collaboration to develop and commercialize COYA 302, an investigational combination therapy for ALS.
In April 2023, CHEPLAPHARM announced that it had reached an agreement with Eli Lilly and Company to acquire the worldwide commercial rights to Zyprexa. The deal concerns the well-established and well-positioned olanzapine/olanzapine pamoate monohydrate ("OPM") portfolio, which includes ZypAdhera / Relprevv (depot IM [2]), Zyprexa IM2 (IM), Zyprexa Zydis / Zyprexa Velotab (ODT form), and Zyprexa (oral form, tablets). This acquisition strengthens the company's portfolio in the therapeutic field of the central nervous system and marks another milestone in CHEPLAPHARM's success story.

Global Olanzapine Market Report Scope:

Historical Data - 2020 - 2021
Base Year for Estimation - 2022
Forecast period - 2023-2030
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered - Application, Route of Administration, Distribution Channel, Region
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope - Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Application:

Schizophrenia
Bipolar Disorder
Others

By Route of Administration:

Oral
Parenteral

By Distribution Channel:

Hospital Pharmacies
Drug stores and Retail Pharmacies
Online Providers

By Region:

North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Chapter 1. Executive Summary

1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
- 1.2.1. Olanzapine Market, by Region, 2020-2030 (USD Billion)
- 1.2.2. Olanzapine Market, by Application, 2020-2030 (USD Billion)
- 1.2.3. Olanzapine Market, by Route of Administration, 2020-2030 (USD Billion)
- 1.2.4. Olanzapine Market, by Distribution Channel, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption

Chapter 2. Global Olanzapine Market Definition and Scope

2.1. Objective of the Study
2.2. Market Definition & Scope
- 2.2.1. Industry Evolution
- 2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates

Chapter 3. Global Olanzapine Market Dynamics

3.1. Olanzapine Market Impact Analysis (2020-2030)
- 3.1.1. Market Drivers
  - 3.1.1.1. Rising prevalence of schizophrenia worldwide
  - 3.1.1.2. Surge in government initiatives for mental disorders
  - 3.1.1.3. Increasing consumer awareness regarding mental diseases
- 3.1.2. Market Challenges
  - 3.1.2.1. High Cost of Olanzapine
  - 3.1.2.2. Adverse effects of formulations
- 3.1.3. Market Opportunities
  - 3.1.3.1. Advancements in olanzapine formulations
  - 3.1.3.2. Rising mental illness

Chapter 4. Global Olanzapine Market Industry Analysis

4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
4.2. Porter's 5 Force Impact Analysis
4.3. PEST Analysis
- 4.3.1. Political
- 4.3.2. Economical
- 4.3.3. Social
- 4.3.4. Technological
- 4.3.5. Environmental
- 4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Olanzapine Market, by Application

5.1. Market Snapshot
5.2. Global Olanzapine Market by Application, Performance - Potential Analysis
5.3. Global Olanzapine Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
5.4. Olanzapine Market, Sub Segment Analysis
- 5.4.1. Schizophrenia
- 5.4.2. Bipolar Disorder
- 5.4.3. Others

Chapter 6. Global Olanzapine Market, by Route of Administration

6.1. Market Snapshot
6.2. Global Olanzapine Market by Route of Administration, Performance - Potential Analysis
6.3. Global Olanzapine Market Estimates & Forecasts by Route of Administration 2020-2030 (USD Billion)
6.4. Olanzapine Market, Sub Segment Analysis
- 6.4.1. Oral
- 6.4.2. Parenteral

Chapter 7. Global Olanzapine Market, by Distribution Channel

7.1. Market Snapshot
7.2. Global Olanzapine Market by Distribution Channel, Performance - Potential Analysis
7.3. Global Olanzapine Market Estimates & Forecasts by Distribution Channel 2020-2030 (USD Billion)
7.4. Olanzapine Market, Sub Segment Analysis
- 7.4.1. Hospital Pharmacies
- 7.4.2. Drug stores and Retail Pharmacies
- 7.4.3. Online Providers

Chapter 8. Global Olanzapine Market, Regional Analysis

8.1. Top Leading Countries
8.2. Top Emerging Countries
8.3. Olanzapine Market, Regional Market Snapshot
8.4. North America Olanzapine Market
- 8.4.1. U.S. Olanzapine Market
  - 8.4.1.1. Application breakdown estimates & forecasts, 2020-2030
  - 8.4.1.2. Route of Administration breakdown estimates & forecasts, 2020-2030
  - 8.4.1.3. Distribution Channel breakdown estimates & forecasts, 2020-2030
- 8.4.2. Canada Olanzapine Market
8.5. Europe Olanzapine Market Snapshot
- 8.5.1. U.K. Olanzapine Market
- 8.5.2. Germany Olanzapine Market
- 8.5.3. France Olanzapine Market
- 8.5.4. Spain Olanzapine Market
- 8.5.5. Italy Olanzapine Market
- 8.5.6. Rest of Europe Olanzapine Market
8.6. Asia-Pacific Olanzapine Market Snapshot
- 8.6.1. China Olanzapine Market
- 8.6.2. India Olanzapine Market
- 8.6.3. Japan Olanzapine Market
- 8.6.4. Australia Olanzapine Market
- 8.6.5. South Korea Olanzapine Market
- 8.6.6. Rest of Asia Pacific Olanzapine Market
8.7. Latin America Olanzapine Market Snapshot
- 8.7.1. Brazil Olanzapine Market
- 8.7.2. Mexico Olanzapine Market
8.8. Middle East & Africa Olanzapine Market
- 8.8.1. Saudi Arabia Olanzapine Market
- 8.8.2. South Africa Olanzapine Market
- 8.8.3. Rest of Middle East & Africa Olanzapine Market

Chapter 9. Competitive Intelligence

9.1. Key Company SWOT Analysis
- 9.1.1. Company 1
- 9.1.2. Company 2
- 9.1.3. Company 3
9.2. Top Market Strategies
9.3. Company Profiles
- 9.3.1. Bristol-Myers Squibb Company
  - 9.3.1.1. Key Information
  - 9.3.1.2. Overview
  - 9.3.1.3. Financial (Subject to Data Availability)
  - 9.3.1.4. Product Summary
  - 9.3.1.5. Recent Developments
- 9.3.2. Dr. Reddy's Laboratories Ltd
- 9.3.3. Endo International plc
- 9.3.4. Teva Pharmaceutical Industries Ltd
- 9.3.5. Sun Pharmaceutical Industries Ltd
- 9.3.6. Mylan N.V.
- 9.3.7. Novartis AG
- 9.3.8. Lupin Ltd.
- 9.3.9. Cipla Inc
- 9.3.10. Eli Lily and Company
- 9.3.11. Research Process
9.4. Research Process
- 9.4.1. Data Mining
- 9.4.2. Analysis
- 9.4.3. Market Estimation
- 9.4.4. Validation
- 9.4.5. Publishing
9.5. Research Attributes
9.6. Research Assumption

LIST OF TABLES

TABLE 1. Global Olanzapine Market, report scope
TABLE 2. Global Olanzapine Market estimates & forecasts by Region 2020-2030 (USD Billion)
TABLE 3. Global Olanzapine Market estimates & forecasts by Application 2020-2030 (USD Billion)
TABLE 4. Global Olanzapine Market estimates & forecasts by Route of Administration 2020-2030 (USD Billion)
TABLE 5. Global Olanzapine Market estimates & forecasts by Distribution Channel 2020-2030 (USD Billion)
TABLE 6. Global Olanzapine Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 7. Global Olanzapine Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 8. Global Olanzapine Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 9. Global Olanzapine Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 10. Global Olanzapine Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 11. Global Olanzapine Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 12. Global Olanzapine Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 13. Global Olanzapine Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 14. Global Olanzapine Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 15. Global Olanzapine Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 16. U.S. Olanzapine Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 17. U.S. Olanzapine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 18. U.S. Olanzapine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 19. Canada Olanzapine Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 20. Canada Olanzapine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 21. Canada Olanzapine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 22. UK Olanzapine Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 23. UK Olanzapine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 24. UK Olanzapine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 25. Germany Olanzapine Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 26. Germany Olanzapine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 27. Germany Olanzapine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 28. France Olanzapine Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 29. France Olanzapine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 30. France Olanzapine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 31. Italy Olanzapine Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 32. Italy Olanzapine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 33. Italy Olanzapine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 34. Spain Olanzapine Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 35. Spain Olanzapine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 36. Spain Olanzapine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 37. RoE Olanzapine Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 38. RoE Olanzapine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 39. RoE Olanzapine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 40. China Olanzapine Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 41. China Olanzapine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 42. China Olanzapine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 43. India Olanzapine Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 44. India Olanzapine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 45. India Olanzapine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 46. Japan Olanzapine Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 47. Japan Olanzapine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 48. Japan Olanzapine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 49. South Korea Olanzapine Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 50. South Korea Olanzapine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 51. South Korea Olanzapine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 52. Australia Olanzapine Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 53. Australia Olanzapine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 54. Australia Olanzapine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 55. RoAPAC Olanzapine Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 56. RoAPAC Olanzapine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 57. RoAPAC Olanzapine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 58. Brazil Olanzapine Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 59. Brazil Olanzapine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 60. Brazil Olanzapine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 61. Mexico Olanzapine Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 62. Mexico Olanzapine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 63. Mexico Olanzapine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 64. RoLA Olanzapine Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 65. RoLA Olanzapine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 66. RoLA Olanzapine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 67. Saudi Arabia Olanzapine Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 68. South Africa Olanzapine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 69. RoMEA Olanzapine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 70. List of secondary sources, used in the study of global Olanzapine Market
TABLE 71. List of primary sources, used in the study of global Olanzapine Market
TABLE 72. Years considered for the study
TABLE 73. Exchange rates considered

List of tables and figures are dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

FIG 1. Global Olanzapine Market, research methodology
FIG 2. Global Olanzapine Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Olanzapine Market, key trends 2022
FIG 5. Global Olanzapine Market, growth prospects 2020-2030
FIG 6. Global Olanzapine Market, porters 5 force model
FIG 7. Global Olanzapine Market, pest analysis
FIG 8. Global Olanzapine Market, value chain analysis
FIG 9. Global Olanzapine Market by segment, 2020 & 2030 (USD Billion)
FIG 10. Global Olanzapine Market by segment, 2020 & 2030 (USD Billion)
FIG 11. Global Olanzapine Market by segment, 2020 & 2030 (USD Billion)
FIG 12. Global Olanzapine Market by segment, 2020 & 2030 (USD Billion)
FIG 13. Global Olanzapine Market by segment, 2020 & 2030 (USD Billion)
FIG 14. Global Olanzapine Market, regional snapshot 2020 & 2030
FIG 15. North America Olanzapine Market 2020 & 2030 (USD Billion)
FIG 16. Europe Olanzapine Market 2020 & 2030 (USD Billion)
FIG 17. Asia pacific Olanzapine Market 2020 & 2030 (USD Billion)
FIG 18. Latin America Olanzapine Market 2020 & 2030 (USD Billion)
FIG 19. Middle East & Africa Olanzapine Market 2020 & 2030 (USD Billion)